CASP3 and cancer: This effect is typically achieved through the activation of the AMPK/SIRT1/NF-κB pathway and the induction of mitochondrial dysfunction, ultimately driving caspase-3/GSDME-mediated cancer cell pyroptosis (Fig. 2).